Ibrahim Khilfeh

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 4

Top Topics

Combination Therapy

Patient Reported

Prognostic Factors

Top Venues

ClinicoEconomics and outcomes research : CEOR

The Journal of dermatological treatment

Journal of comparative effectiveness research

Open access rheumatology : research and reviews

This page only lists publications with an associated author ORCID identifier.

Publications

M Elaine Husni, Eunice Chang, Michael S Broder, Caleb Paydar, Katalin Bognar, Pooja Desai, Yuri Klyachkin, Ibrahim Khilfeh
Biologic Initiation Rate in Systemic-Naïve Psoriatic Arthritis Patients Starting Treatment with Apremilast vs Methotrexate: 1-Year Retrospective Analysis of a US Claims Database. Open access rheumatology : research and reviews 14 (2022)
David Kaplan, James Hetherington, James Lucas, Ibrahim Khilfeh, Tara Nazareth
Real-world health outcomes in US adult patients with mild to moderate plaque psoriasis taking topical therapy. The Journal of dermatological treatment 33 (6) (2022)
David Kaplan, M Elaine Husni, Eunice Chang, Michael S Broder, Caleb Paydar, Katalin Bognar, Jessie Yan, Sven Richter, Pooja Desai, Ibrahim Khilfeh
Biologic initiation rates in systemic-naive psoriasis patients after first-line apremilast versus methotrexate use. Journal of comparative effectiveness research 11 (8) (2022)
David L Kaplan, Brian L Ung, Corey Pelletier, Chuka Udeze, Ibrahim Khilfeh, Marc Tian
Switch Rates and Total Cost of Care Associated with Apremilast and Biologic Therapies in Biologic-Naive Patients with Plaque Psoriasis. ClinicoEconomics and outcomes research : CEOR 12 (2020)